An Isothermal Method for Sensitive Detection of Mycobacterium tuberculosis Complex Using Clustered Regularly Interspaced Short Palindromic Repeats/Cas12a Cis and Trans Cleavage

劈理(地质) 清脆的 结核分枝杆菌 生物 回文 遗传学 计算生物学 肺结核 分子生物学 医学 基因 病理 古生物学 断裂(地质)
作者
Haipo Xu,Xiaolong Zhang,Zhixiong Cai,Xiuqing Dong,Geng Chen,Zhenli Li,Liman Qiu,Lei He,Bin Liang,Xiaolong Liu,Jingfeng Liu
出处
期刊:The Journal of Molecular Diagnostics [Elsevier BV]
卷期号:22 (8): 1020-1029 被引量:54
标识
DOI:10.1016/j.jmoldx.2020.04.212
摘要

Tuberculosis is one of the most serious infectious diseases, resulting in death worldwide. Traditional detection methods are not enough to meet the clinical requirements of rapid diagnosis, high specificity, and high sensitivity. Fast, sensitive, and accurate detection of Mycobacterium tuberculosis (MTB) is urgently needed to treat and control tuberculosis disease. Clustered regularly interspaced short palindromic repeats (CRISPR)–associated proteins (Cas12a) exhibit strong nonspecific degradation ability of exogenous single-strand nucleic acids (trans cleavage) after specific recognition of target sequence. We purified Cas12a protein and selected a proper guide RNA based on conserved sequences of MTB from designed guide RNA library. Then, we proposed a novel detection method based on recombinase polymerase amplification and CRISPR/Cas12a nuclease system for specific and sensitive detection of MTB DNA. The assay, based on fluorescence detection, showed 4.48 fmol/L of limit of detection and good linear correlation of concentration with fluorescence value (R2 = 0.9775). It also showed good performance in distinguishing other bacteria. Furthermore, its clinical performance was evaluated by 193 samples and showed sensitivity of 99.29% (139/140) and specificity of 100% (53/53) at 99% CI, compared with culture method. Taken together, the CRISPR/Cas12a system showed good specificity, excellent sensitivity, and excellent accuracy for MTB detection, and it meets requirements of MTB detection in clinical samples and has great potential for clinical translation. Tuberculosis is one of the most serious infectious diseases, resulting in death worldwide. Traditional detection methods are not enough to meet the clinical requirements of rapid diagnosis, high specificity, and high sensitivity. Fast, sensitive, and accurate detection of Mycobacterium tuberculosis (MTB) is urgently needed to treat and control tuberculosis disease. Clustered regularly interspaced short palindromic repeats (CRISPR)–associated proteins (Cas12a) exhibit strong nonspecific degradation ability of exogenous single-strand nucleic acids (trans cleavage) after specific recognition of target sequence. We purified Cas12a protein and selected a proper guide RNA based on conserved sequences of MTB from designed guide RNA library. Then, we proposed a novel detection method based on recombinase polymerase amplification and CRISPR/Cas12a nuclease system for specific and sensitive detection of MTB DNA. The assay, based on fluorescence detection, showed 4.48 fmol/L of limit of detection and good linear correlation of concentration with fluorescence value (R2 = 0.9775). It also showed good performance in distinguishing other bacteria. Furthermore, its clinical performance was evaluated by 193 samples and showed sensitivity of 99.29% (139/140) and specificity of 100% (53/53) at 99% CI, compared with culture method. Taken together, the CRISPR/Cas12a system showed good specificity, excellent sensitivity, and excellent accuracy for MTB detection, and it meets requirements of MTB detection in clinical samples and has great potential for clinical translation. Tuberculosis (TB),1Donoghue M. Hsieh F. Baronas E. Godbout K. Gosselin M. Stagliano N. Donovan M. Woolf B. Robison K. Jeyaseelan R. Breitbart R.E. Acton S. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9.Circ Res. 2000; 87: E1-E9Crossref PubMed Google Scholar which is caused by Mycobacterium tuberculosis (MTB) and could spread through aerosol in the air (eg, by coughing), remains one of the top 10 causes of death and the leading cause of death from a single infectious agent (ranking above HIV/AIDS) worldwide (global tuberculosis report 2018, https://www.who.int/tb/publications/2018/en/, last accessed April 24, 2020). Therefore, the fast, sensitive, and accurate diagnosis of active TB and drug resistance (eg, rifampicin, isoniazid, and pyrazinamide) is crucial both for the individual and population level to reduce morbidity, mortality, and transmission among patients. Sputum smear microscopy is the primary test for TB diagnosis, but it is significantly limited by its laborious detection process and relatively low detection sensitivity of only 56% to 68%2Denkinger C.M. Kik S.V. Madhukar P. Robust, reliable and resilient: designing molecular tuberculosis tests for microscopy centers in developing countries.Expert Rev Mol Diagn. 2013; 13: 763-767Crossref PubMed Scopus (25) Google Scholar (global tuberculosis control: a short update to the 2009 report, https://www.who.int/tb/publications/2009/en/, last accessed April 24, 2020). In addition, the microscopy performs poorly on HIV co-infected specimens because the amount of MTB is low in sputum specimen. Meanwhile, it cannot distinguish MTB and nontuberculosis mycobacteria, which are treated totally differently because of different pathogenicity and drug susceptibility profiles,3Griffith D.E. Timothy A. Brown-Elliott B.A. Antonino C. Charles D. Fred G. Holland S.M. Robert H. Gwen H. Iademarco M.F. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.Am J Respir Crit Care Med. 2007; 175: 367-416Crossref PubMed Scopus (4303) Google Scholar, 4Nie W. Duan H. Huang H. Lu Y. Chu N. Species identification and clarithromycin susceptibility testing of 278 clinical nontuberculosis mycobacteria isolates.Biomed Res Int. 2015; 2015: 506598Crossref PubMed Scopus (14) Google Scholar, 5Wang X.L.H. Jiang G. Zhao L. Ma Y. Javid B. Huang H. Prevalence and drug resistance of nontuberculous mycobacteria, northern China, 2008-2011.Emerg Infect Dis. 2014; 20: 1252-1253Crossref PubMed Scopus (32) Google Scholar although they show similar clinical manifestation. So far, culture-based mycobacterial detection method is still the gold standard for the laboratory diagnosis of tuberculosis because of its high sensitivity, specificity, and accuracy.6Parrish N.M. Carroll K.C. Role of the clinical mycobacteriology laboratory in diagnosis and management of tuberculosis in low-prevalence settings.J Clin Microbiol. 2011; 49: 772-776Crossref PubMed Scopus (46) Google Scholar But it needs extensive laboratory experience and usually takes up to 4 to 6 weeks to achieve satisfied results, which does not meet the rapid test requirement. This has significantly hindered the prompt treatment and isolation of patients, which is crucial for disease control. Moreover, some bacilli cannot be successfully cultured, which might cause error results.7Sgaragli G. Frosini M. Human tuberculosis I: epidemiology, diagnosis and pathogenetic mechanisms.Curr Med Chem. 2016; 23: 2836-2873Crossref PubMed Scopus (26) Google Scholar Genetic sequencing of MTB DNA was reported to be a more accurate strategy for TB diagnosis. The Xpert MTB/RIF system (Cepheid, Sunnyvale, CA), a PCR-based test, is the only one accepted by the World Health Organization from 2010 for detecting TB infection and rifampicin resistance. Although it has many advantages, including full automation, integration, and better accuracy than microscopy or culture methods, its sensitivity for some bacilli clinical specimens is still inadequate. Furthermore, the cost of cartridges, instrumentation, and maintenance of Xpert MTB/RIF system make it impossible to set up in many high TB burden countries, which further limited its usefulness.8Machado D. Couto I. Viveiros M. Advances in the molecular diagnosis of tuberculosis: from probes to genomes.Infect Genet Evol. 2019; 72: 93-112Crossref PubMed Scopus (25) Google Scholar,9Boyle D.S. Mcnerney R. Teng L.H. Leader B.T. Pérez-Osorio A.C. Meyer J.C. O'Sullivan D.M. Brooks D.G. Piepenburg O. Forrest M.S. Rapid detection of Mycobacterium tuberculosis by recombinase polymerase amplification.PLoS One. 2014; 9: e103091Crossref PubMed Scopus (108) Google Scholar In recent years, isothermal amplification assays, using loop-mediated amplification,10Nimitphak T. Kiatpathomchai W. Flegel T.W. Loop-mediated isothermal amplification of DNA.Nucleic Acids Res. 2000; 28: E63Crossref PubMed Scopus (5734) Google Scholar helicase-dependent amplification,11Vincent M. Xu Y. Kong H. Helicase-dependent isothermal DNA amplification.EMBO Rep. 2004; 5: 795-800Crossref PubMed Scopus (614) Google Scholar and recombinase polymerase amplification (RPA),12Piepenburg O. Williams C.H. Stemple D.L. Armes N.A. DNA detection using recombination proteins.PLoS Biol. 2006; 4: 1115-1121Crossref Scopus (1240) Google Scholar, 13Li J. Macdonald J. Stetten F.V. Review: a comprehensive summary of a decade development of the recombinase polymerase amplification.Analyst. 2018; 144: 31-67Crossref PubMed Google Scholar, 14Daher R.K. Stewart G. Boissinot M. Bergeron M.G. Recombinase polymerase amplification for diagnostic applications.Clin Chem. 2016; 62: 947-958Crossref PubMed Scopus (321) Google Scholar have been extensively applied in the field of molecular diagnosis, including pulmonary TB diagnosis.9Boyle D.S. Mcnerney R. Teng L.H. Leader B.T. Pérez-Osorio A.C. Meyer J.C. O'Sullivan D.M. Brooks D.G. Piepenburg O. Forrest M.S. Rapid detection of Mycobacterium tuberculosis by recombinase polymerase amplification.PLoS One. 2014; 9: e103091Crossref PubMed Scopus (108) Google Scholar,15Boehme C.C. Pamela N. German H. Rubhana R. Zeaur R. Martina G. Erica S. Michael H. Tsugunori N. Tetsu H. Operational feasibility of using loop-mediated isothermal amplification for diagnosis of pulmonary tuberculosis in microscopy centers of developing countries.J Clin Microbiol. 2007; 45: 1936-1940Crossref PubMed Scopus (277) Google Scholar,16Wanyuan A. Stephen A. Evelyn W. Brian H. Larry R. Barry K. Robert J. Rapid detection of rpoB gene mutations conferring rifampin resistance in Mycobacterium tuberculosis.J Clin Microbiol. 2012; 50: 2433-2440Crossref PubMed Scopus (29) Google Scholar Especially, the RPA reaction, which replaces the thermal cycles needed for PCR and works at temperatures between 25°C and 42°C with three core enzymes, permits rapid DNA amplification in minutes. Recently, the RPA-based methods have been used for detection of MTB and other pathogens, whereas it always had high false-positive rates in clinical samples.17Daher R.K. Stewart G. Boissinot M. Boudreau D.K. Bergeron M.G. Influence of sequence mismatches on the specificity of recombinase polymerase amplification technology.Mol Cell Probes. 2015; 29: 116-121Crossref PubMed Scopus (112) Google Scholar To further improve specificity, long oligonucleotide probe with fluorophores and quenchers or other modifications of probe, such as biotin and tetrahydrofuran, has been designed to recognize RPA amplicon for specific cleavage by nucleases, and these newly developed methods have been successfully applied for pathogen diagnosis,18Nguyen D.T.T. Lee E.Y. Koo B. Jin C.E. Lee T.Y. Yong S. A microfluidic enrichment platform with a recombinase polymerase amplification sensor for pathogen diagnosis.Anal Biochem. 2017; 544: 87-92PubMed Google Scholar, 19Peng Z. Gao W. Huang H. Jiang J. Chen X. Fan J. Yan X. Rapid detection of Vibrio parahaemolyticus in shellfish by real-time recombinase polymerase amplification.Food Anal Methods. 2018; 11: 1-9Google Scholar, 20Kersting S. Rausch V. Bier F.F. Nickisch-Rosenegk M.V. Multiplex isothermal solid-phase recombinase polymerase amplification for the specific and fast DNA-based detection of three bacterial pathogens.Microchim Acta. 2014; 181: 1715-1723Crossref PubMed Scopus (131) Google Scholar liquid biopsy,21Mauk M.G. Liu C. Sadik M. Bau H.H. Microfluidic devices for nucleic acid (NA) isolation, isothermal NA amplification, and real-time detection.Methods Mol Biol. 2015; 1256: 15Crossref PubMed Scopus (33) Google Scholar and single-nucleotide polymorphism/genotyping.22Yamanaka E.S. Tortajada-Genaro L.A. Maquieira Á. Low-cost genotyping method based on allele-specific recombinase polymerase amplification and colorimetric microarray detection.Microchim Acta. 2017; 184: 1453-1462Crossref Scopus (34) Google Scholar However, the synthesis of long oligonucleotide probes with multiple modifications is costly, and different probes with the same amplified region may also affect the efficiency of RPA. Especially, the base mismatches near the middle of probes or the 3′-OH end of primers might significantly affect the efficiency of RPA reaction, which could lead to reduced amplification efficiency and false-positive results.17Daher R.K. Stewart G. Boissinot M. Boudreau D.K. Bergeron M.G. Influence of sequence mismatches on the specificity of recombinase polymerase amplification technology.Mol Cell Probes. 2015; 29: 116-121Crossref PubMed Scopus (112) Google Scholar,23Liu X.Y.Q. Huang J. Chen J. Guo Z. Liu Z. Cai L. Li R. Wang Y. Yang G. Lan Q. Influence of design probe and sequence mismatches on the efficiency of fluorescent RPA.World J Microbiol Biotechnol. 2019; 35: 95Crossref PubMed Scopus (19) Google Scholar Microbial clustered regularly interspaced short palindromic repeats (CRISPR)–associated protein (Cas) adaptive immune system consists of guide RNA(s) [gRNA(s)] for target recognition and a Cas enzyme for target cleavage.24Chen J.S. Ma E. Harrington L.B. Costa M.D. Doudna J.A. CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity.Science. 2018; 360: 436-439Crossref PubMed Scopus (1403) Google Scholar, 25Martin J. Krzysztof C. Ines F. Michael H. Doudna J.A. Emmanuelle C. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.Science. 2012; 337: 816-821Crossref PubMed Scopus (9327) Google Scholar, 26Rodolphe B. Christophe F. Hélène D. Melissa R. Patrick B. Sylvain M. Romero D.A. Philippe H. CRISPR provides acquired resistance against viruses in prokaryotes.Science. 2007; 315: 1709-1712Crossref PubMed Scopus (3829) Google Scholar, 27Ran F.A. Hsu P.D. Wright J. Agarwala V. Scott D.A. Zhang F. Genome engineering using the CRISPR-Cas9 system.Nat Protoc. 2013; 8: 2281Crossref PubMed Scopus (6410) Google Scholar The sequence-specific recognition capabilities of the CRISPR-Cas system make it a promising genome engineering tool for genome editing,27Ran F.A. Hsu P.D. Wright J. Agarwala V. Scott D.A. Zhang F. Genome engineering using the CRISPR-Cas9 system.Nat Protoc. 2013; 8: 2281Crossref PubMed Scopus (6410) Google Scholar,28Le C. Ran F.A. David C. Shuailiang L. Robert B. Naomi H. Hsu P.D. Xuebing W. Wenyan J. Marraffini L.A. Multiplex genome engineering using CRISPR/Cas systems.Science. 2015; 339: 819-823Google Scholar cancer target therapy,29Manguso R.T. Pope H.W. Zimmer M.D. Brown F.D. Yates K.B. Miller B.C. Collins N.B. Bi K. Lafleur M.W. Juneja V.R. In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target.Nature. 2017; 547: 413Crossref PubMed Scopus (568) Google Scholar and gene therapy.30Lu X.J. Xue H.Y. Ke Z.P. Chen J.L. Ji L.J. CRISPR-Cas9: a new and promising player in gene therapy.J Med Genet. 2015; 52: 289-296Crossref PubMed Scopus (122) Google Scholar Recently, the CRISPR-Cas nuclease systems (Cas12, Cas13, and Cas14)24Chen J.S. Ma E. Harrington L.B. Costa M.D. Doudna J.A. CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity.Science. 2018; 360: 436-439Crossref PubMed Scopus (1403) Google Scholar,31Gootenberg J.S.A.O. Lee J.W. Essletzbichler P. Dy A.J. Joung J. Verdine V. Donghia N. Daringer N.M. Freije C.A. Myhrvold C. Bhattacharyya R.P. Livny J. Regev A. Koonin E.V. Hung D.T. Sabeti P.C. Collins J.J. Zhang F. Nucleic acid detection with CRISPR-Cas13a/C2c2.Science. 2017; 356: 438-442Crossref PubMed Scopus (1475) Google Scholar, 32Gootenberg J.S. Abudayyeh O.O. Kellner M.J. Joung J. Collins J.J. Zhang F. Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6.Science. 2018; 360: 439-444Crossref PubMed Scopus (1057) Google Scholar, 33Harrington L.B. Burstein D. Chen J.S. Paez-Espino D. Ma E. Witte I.P. Cofsky J.C. Kyrpides N.C. Banfield J.F. Doudna J.A. Programmed DNA destruction by miniature CRISPR-Cas14 enzymes.Science. 2018; 362: 839-842Crossref PubMed Scopus (471) Google Scholar also have been developed for nucleic acid detection with high sensitivity and specificity. These CRISPR-Cas nuclease systems use the gRNA to recognize the RNA (Cas13a and Cas13b) or DNA (Cas12a and Cas14) targets, then are followed by activating cleavage capacity of Cas nuclease to degrade multiple foreign nucleic acid reporters for target detection. Combining with nucleic acid amplification strategy, the Cas nuclease systems have been used for highly sensitive and specific detection of nucleic acids and became powerful tools for developing molecular diagnostic techniques.24Chen J.S. Ma E. Harrington L.B. Costa M.D. Doudna J.A. CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity.Science. 2018; 360: 436-439Crossref PubMed Scopus (1403) Google Scholar,31Gootenberg J.S.A.O. Lee J.W. Essletzbichler P. Dy A.J. Joung J. Verdine V. Donghia N. Daringer N.M. Freije C.A. Myhrvold C. Bhattacharyya R.P. Livny J. Regev A. Koonin E.V. Hung D.T. Sabeti P.C. Collins J.J. Zhang F. Nucleic acid detection with CRISPR-Cas13a/C2c2.Science. 2017; 356: 438-442Crossref PubMed Scopus (1475) Google Scholar,32Gootenberg J.S. Abudayyeh O.O. Kellner M.J. Joung J. Collins J.J. Zhang F. Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6.Science. 2018; 360: 439-444Crossref PubMed Scopus (1057) Google Scholar To achieve prompt, sensitive, and specific confirmed diagnosis of MTB, herein the RPA reaction is combined with the CRISPR-Cas nuclease (Cas12a) system to develop a novel MTB DNA detection method (Figure 1). First, the sequence of MTB with protospacer adjacent motif structure (5′-TTTN-3′) for Cas12/gRNA recognition was selected for gRNA design. The gRNA consists of two parts, universal spacer sequence (5′-UAAUUUCUACUAAGUGUAGAU-3′) at the 5′ end (also near the protospacer adjacent motif structure end) and specific sequence at the 3′ end. And gRNAs were selected via evaluating by multiple software programs, such as CRISPR-DT, NUPACK, and Nucleotide BLAST. Then, the feasibility of Cas12a/gRNA trans-cleavage reaction was validated by the purified Cas12a. Subsequently, the suitable amplicon screening was performed and tested to effectively avoid false amplification of RPA. In the Cas12a/gRNA trans-cleavage fluorescence assay for MTB, in the presence of MTB DNA, they could be amplified by RPA reaction. Later, through Cas12a/gRNA complexes binding to amplified MTB DNA, Cas12a mediated non-specific degradation of non-specific fluorescent probes, which were polythymidine oligonucleotides with fluorophore at the 5′ end and quencher at the 3′ end, as MTB DNA reporters, that could release the fluorophores from the quenchers to increase fluorescence intensities for detection. The current article proposes a novel isothermal method based on RPA and CRISPR-Cas system, which has low limitation on MTB detection in the model testing system, with 4.48 fmol/L of limit of detection (LOD), ranging over six orders of magnitude (R2 = 0.9775), and could be applied to practical applications on clinical samples with excellent specificity, sensitivity, and accuracy, which are comparable with the result of the gold standard of culture method. MTB-specific fragment of the insertion sequence IS1081, which exists in all MTB complexes,34Collins D.M. Stephens D.M. Identification of an insertion sequence, IS1081, in Mycobacterium bovis.FEMS Microbiol Lett. 1991; 67: 11-15Crossref PubMed Scopus (121) Google Scholar was selected as the target sequence for design of gRNA to target MTB and RPA reaction primers. To obtain the suitable guide RNA for MTB, gRNAs targeting IS1081 double-stranded DNA were designed and scored by CRISPR-DT online software for Cpf1 (Cas12a; http://bioinfolab.miamioh.edu/CRISPR-DT/interface/Cpf1_main.php, last accessed April 24, 2020), and target efficiency <0.6 was excluded. Meanwhile, the second structure and homology of remaining gRNAs were further evaluated by NUPACK (http://www.nupack.org/, last accessed April 24, 2020) and Nucleotide BLAST (https://blast.ncbi.nlm.nih.gov/Blast.cgi?PROGRAM=blastn&PAGE_TYPE=BlastSearch&LINK_LOC=blasthome), respectively. Afterward, RPA primers were designed through Primer Premier software version 5.0 (Premier Biosoft International, San Francisco, CA) and selected using agarose gel electrophoresis, according to the TwistAmp Assay Design Manual (TwistDx Ltd, Cambridge, MA). All RNA, IS1081 or IS6110 segments and modified DNA oligonucleotides were synthesized by General Biosystems (Anhui, China). Plasmids obtained from the constructs of the segment of Mycobacterium bovis transposase insertion sequence element, IS1081 (gene ID: 32286187, https://www.ncbi.nlm.nih.gov/gene/) and IS6110 (GenBank: X17348.1, https://www.ncbi.nlm.nih.gov/nuccore/), were put into vector PUC57. Sequence information can be seen in Supplemental Table S1. The fluorescent polyoligonucleotides probe [single-stranded DNA (ssDNA)–fluorophore quencher (FQ)] was labeled with a fluorescent dye at the 5′ end and a quenching group at the 3′ end and then purified with high-performance liquid chromatography. The fluorescence could be detected only when the fluorescent dye and quenching group were separated. Forward and reverse primers for RPA and non-specific ssDNA (nontarget) for Cas12a/gRNA trans-cleavage reaction were obtained from Sangon Biotech (Shanghai, China) with PAGE purification. All DNA/RNA oligonucleotides and plasmids were diluted with RNase-free water, and the concentrations were determined by Nanodrop 200 (Thermo Fisher Scientific, Waltham, MA). All of these were stored at −20°C until use. The sequences of DNA/RNA oligonucleotides used in the assay are shown in Table 1 and Table 2.Table 1The Oligonucleotide Sequences of RPA Primers and Non-Specific ssDNA for Setup of MTB Cas12a/gRNA Trans-Cleavage AssayNameSequenceRPA-F1∗RPA-F and RPA-R are the forward and reverse primers of RPA, respectively. The final sequences of RPA primers are marked.5′-CCAAGCTGCGCCAGGGCAGCTATTTCCCGGAC-3′RPA-F25′-CAAGCGAGCTGAACGCGCACTGACCAGCGT-3′RPA-F35′-GGTGGCGACCTGCTACCTGCTGGGAGTAT-3′RPA-R1∗RPA-F and RPA-R are the forward and reverse primers of RPA, respectively. The final sequences of RPA primers are marked.5′-TTGGCCATGATCGACACTTGCGACTTGGA-3′RPA-R25′-CGAAACGCCTCTACGGCTTCGTCGAGCTC-3′RPA-R35′-GGCGTCGGCGGCGAGGAAGGTATACGG-3′ssDNA (nontarget)5′-GCTTGTGGCCGTTTACGTCGCCGTCCAGCTCGACCAGGATGGGCACCACCCCGGCTTTTTTTTTTTTTTTTTTTTTTTT-3′ssDNA-FQ5′-FAM-TTTTT-BHQ1-3′ssDNA (nontarget) was used in the Cas12a/gRNA assay, and ssDNA-FQ was used in the Cas12a/gRNA trans-cleavage fluorescence assay.FQ, fluorophore quencher; gRNA, guide RNA; MTB, Mycobacterium tuberculosis; RPA, recombinase polymerase amplification; ssDNA, single-stranded DNA.∗ RPA-F and RPA-R are the forward and reverse primers of RPA, respectively. The final sequences of RPA primers are marked. Open table in a new tab Table 2The Sequences of Designed gRNAs Targeting IS1081 and the Corresponding Target Efficiency Score for MTB GenomeNameSequenceTarget strandTarget efficiency scoregRNA 15′-UAAUUUCUACUAAGUGUAGAUGUCAACCCAGCACCUGCCAG-3′Antisense0.9725gRNA 25′-UAAUUUCUACUAAGUGUAGAUGACACCCGTGCCGCAACCAT-3′Antisense0.9639gRNA 35′-UAAUUUCUACUAAGUGUAGAUGAAGGAUCACGCGAUGACCG-3′Sense0.8954gRNA 45′-UAAUUUCUACUAAGUGUAGAUACCACACCUUGGGGCACCUU-3′Antisense0.8461gRNA 55′-UAAUUUCUACUAAGUGUAGAUGCCAUGAUCGACACUUGCGA-3′Sense0.838gRNA 65′-UAAUUUCUACUAAGUGUAGAUCAAGUCGCAAGUGUCGAUCA-3′Antisense0.7736gRNA 75′-UAAUUUCUACUAAGUGUAGAUUCGGUCAGAGCGUCGAGUAC-3′Sense0.7692gRNA 85′-UAAUUUCUACUAAGUGUAGAUGGACCCGCCCGCUCGAUGCC-3′Antisense0.7227gRNA 9∗The final sequence of gRNA used in the MTB Cas12a trans-cleavage fluorescence assay.5′-UAAUUUCUACUAAGUGUAGAUGACCAGGCGCUCCAUCCGGC-3′Sense0.7061gRNA 105′-UAAUUUCUACUAAGUGUAGAUGCGCCAGAUCUGCUUGGGGA-3′Sense0.5644gRNA 115′-UAAUUUCUACUAAGUGUAGAUUCACACCAAGUGUUUCGACC-3′Sense0.5353gRNA 125′-UAAUUUCUACUAAGUGUAGAUCUGGUCGUUUCGAAGGAUCA-3′Sense0.4128gRNA 135′-UAAUUUCUACUAAGUGUAGAUCCGGACUGGCUGCUGCAGCG-3′Antisense0.2013gRNA 145′-UAAUUUCUACUAAGUGUAGAUCUGCUUGGCGGGUUCUUCGG-3′Sense0.0606gRNA 155′-UAAUUUCUACUAAGUGUAGAUUUUCCUUCGAUUGACUCUGG-3′Sense0.0107gRNA, guide RNA; MTB, Mycobacterium tuberculosis.∗ The final sequence of gRNA used in the MTB Cas12a trans-cleavage fluorescence assay. Open table in a new tab ssDNA (nontarget) was used in the Cas12a/gRNA assay, and ssDNA-FQ was used in the Cas12a/gRNA trans-cleavage fluorescence assay. FQ, fluorophore quencher; gRNA, guide RNA; MTB, Mycobacterium tuberculosis; RPA, recombinase polymerase amplification; ssDNA, single-stranded DNA. gRNA, guide RNA; MTB, Mycobacterium tuberculosis. The DNA plasmid encoding Cas12a (alias Cpf1) with 6× His-tag, maltose-binding protein, and tobacco etch virus (TEV) protease cleavage site was selected for LbCas12a expression. The plasmid 6His–maltose-binding protein–TEV-huLbCpf1 (plasmid 90096) (Supplemental Figure S1 and Supplemental Table S1) was purchased from Addgene (Cambridge, MA). After extraction from amplified strains, the plasmids were transformed into BL21 (DE3) pLysS Chemically Competent Cells (TransGen Biotech Co, Ltd, Beijing, China). Then, transformed strains were recovered from Luria-Bertani solid growth media and turned to 5 mL Luria-Bertani liquid growth media. The LbaCas12a protein was then expressed and purified, according to the method described by Chen et al.24Chen J.S. Ma E. Harrington L.B. Costa M.D. Doudna J.A. CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity.Science. 2018; 360: 436-439Crossref PubMed Scopus (1403) Google Scholar Briefly, a 5-mL starter culture was grown in Luria-Bertani liquid growth media (containing 10 g/L tryptone, 5 g/L yeast extract, and 10 g/L NaCl, pH 7.0; Sigma, St. Louis, MO) at 25°C overnight, and then further transferred into 1 L of Luria-Bertani liquid growth media and inoculated for growth at 37°C under 300 rpm shaking until the OD 600 reached approximately 0.6. Afterward, all bacterium was cooled down and supplemented with 500 μmol/L isopropyl-1-thio-b-d-galactopyranoside (TransGen Biotech Co, Ltd) at 16°C for 16 hours to allow protein expression. After centrifugation at 2600 × g for 30 minutes at 4°C, the bacterial precipitation was harvested and stored at −80°C until use. The protein purification was performed at 4°C. First, the bacterial precipitation was crushed and lysed by sonication in lysis buffer [50 mmol/L Tris-HCl, 500 mmol/L NaCl, 5% (v/v) glycerol, 1 mmol/L Tris(2-carboxyethyl)phosphine (TCEP), 0.5 mmol/L phenylmethylsulfonyl fluoride, and 0.25 mg/mL lysozyme, pH 7.5]. After centrifugation, the supernatant was filtered via a Stericup 0.22-μm filter (EMD Millipore, Hong Kong, China). The filtered supernatant was pipetted to Ni-NTA resin (GE Healthcare, Chicago, IL) for 30 minutes, and washed with lysis buffer. Then, the resin was resuspended in 1× TEV digestion buffer (50 mmol/L Tris-HCl, 50 mmol/L NaCl, 0.5 mmol/L EDTA, and 1 mmol/L dithiothreitol, pH 8.0) with 250 units of TEV protease (Beyotime Biotechnology, Shanghai, China) overnight at 4°C with rotation. To obtain purer proteins, the steps on Ni-NTA resin were repeated. The protease-treated LbCas12a was dialyzed in buffer A (20 mmol/L Tris-HCl, 125 mmol/L KCl, 5% glycerol, and 1 mmol/L TCEP, pH 7.5) for three times at 4°C, and further purified on a 5-mL HiTrap SP HP sepharose column (GE Healthcare, Boston, MA). After washing with three column volumes of buffer A, LbCas12a was eluted using a linear gradient from 0% to 100% buffer B (20 mmol/L Tris-HCl, 1 mol/L KCl, 5% glycerol, and 1 mmol/L TCEP, pH 7.5) over 20 column volumes. The eluted proteins were further purified on a Superdex 200 column (GE Healthcare, Boston, MA) with elution buffer (20 mmol/L Tris-HCl, 200 mmol/L KCl, 5% glycerol, and 1 mmol/L TCEP, pH 7.5). The existence of LbCas12a protein was confirmed by SDS-PAGE and Coomassie Blue staining, and then mixed with equal volume of glycerol after quantification and stored at −20°C for further use. To test the cis- and trans-cleavage activity of purified LbCas12a protein and the feasibility of Cas12/gRNA trans cleavage for MTB detection, the alteration of amount and integrity of substrates and non-specific single-stranded DNA by 4% agarose gel electrophoresis was observed, and the fluorescence intensity was collected by detector with/out target plasmid, gRNA, or nontarget ssDNA. The Cas12a/gRNA trans cleavage for MTB detection assay was as follows: 50 nmol/L LbCas12a incubating with 36 nmol/L IS1081-gRNA, 80 ng IS1081 plasmid, and 50 nmol/L nontarget ssDNA (replaced with ssDNA-FQ in Cas12a/gRNA fluorescence assay) in 1× reaction buffer (50 mmol/L NaCl, 10 mmol/L Tris-HCl, 10 mmol/L MgCl2, and 100 μg/mL bovine serum albumin, pH 7.9), incubated at 37°C for 2 hours. To improve signal amplification efficiency and simplify operation, 1 μL of DNA extracted from amplified clone strains as template was added into RPA reaction mixture of 12.5 μL volume. RPA reaction mixture, including 0.24 to 0.72 μmol/L forward and reverse primers, 1.8 mmol/L dNTP, 1× reaction buffer, 1× basic E-mix, 0.625 μL 20× core reaction mix, 1 μL genome, and 14 mmol/L magnesium acetate and diethyl pyrocarbonate water up to 12.5 μL, was incubated at 37°C to 42°C for 1 hour. According to the TwistAmp Assay Design Manual, multiplex sets of RPA primers were selected as candidates, including primers from published literature9Boyle D.S. Mcnerney R. Teng L.H. Leader B.T. Pérez-Osorio A.C. Meyer J.C. O'Sullivan D.M. Brooks D.G. Piepenburg O. Forrest M.S. Rapid detection of Mycobacterium tuberculosis by recombinase polymerase amplification.PLoS One. 2014; 9: e103091Crossref PubMed Scopus (108) Google Scholar,35Ma Q. Liu H. Ye F. Xiang G
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
英姑的应助被shan采纳,获得10
刚刚
刚刚
刚刚
Zeus完成签到,获得积分10
1秒前
1秒前
1秒前
Charison发布了新的文献求助10
1秒前
Beginner完成签到,获得积分10
1秒前
2秒前
我是老大的应助被温潮生采纳,获得10
2秒前
CipherSage的应助被nn114采纳,获得30
2秒前
Gmy完成签到 ,获得积分10
2秒前
hjk完成签到,获得积分10
2秒前
kkk完成签到,获得积分20
2秒前
3秒前
even完成签到 ,获得积分10
3秒前
蕲艾比比谁完成签到,获得积分10
3秒前
wanci的应助被陈曦读研版采纳,获得10
3秒前
陈泽宇发布了新的文献求助10
3秒前
虚心灵煌完成签到,获得积分10
4秒前
237完成签到,获得积分10
4秒前
仄言完成签到,获得积分10
5秒前
渡边卯卯完成签到,获得积分10
5秒前
Hello的应助被liu采纳,获得10
5秒前
dashuaicai完成签到,获得积分20
5秒前
kkk发布了新的文献求助10
5秒前
5秒前
wang完成签到,获得积分10
5秒前
5秒前
Lucas的应助被咩了个咩采纳,获得10
6秒前
黑猫黑猫发布了新的文献求助10
6秒前
午凌二发布了新的文献求助30
6秒前
6秒前
7秒前
7秒前
无极微光的应助被enuiu采纳,获得20
7秒前
元灿霓发布了新的文献求助10
8秒前
8秒前
科研小白发布了新的文献求助10
9秒前
仄言发布了新的文献求助10
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8161749
求助须知:如何正确求助?哪些是违规求助? 9556240
关于积分的说明 21733360
捐赠科研通 7751657
什么是DOI,文献DOI怎么找? 3427566
关于科研通互助平台的介绍 2552632
邀请新用户注册赠送积分活动 2472047